(Q44845531)

6 December 2017

title

Practical and analytic issues in the electronic assessment of adherence (English)

1 reference

6 December 2017

Paul Cook

1

1 reference

6 December 2017

Sarah Schmiege

2

1 reference

6 December 2017

Margaret McClean

3

1 reference

6 December 2017

Laurra Aagaard

4

1 reference

6 December 2017

Malik Kahook

5

1 reference

6 December 2017

publication date

18 November 2011

1 reference

Western Journal of Nursing Research

6 December 2017

published in

1 reference

6 December 2017

volume

34

1 reference

6 December 2017

issue

5

1 reference

6 December 2017

page(s)

598-620

1 reference

Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness.

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0193945911427153

Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0193945911427153

A single tablet regimen is associated with higher adherence and viral suppression than multiple tablet regimens in HIV+ homeless and marginally housed people

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0193945911427153

The elusive gold standard. Future perspectives for HIV adherence assessment and intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0193945911427153

Telephone counseling to improve osteoporosis treatment adherence: an effectiveness study in community practice settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0193945911427153

Diagnostic Value of Different Adherence Measures Using Electronic Monitoring and Virologic Failure as Reference Standards

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0193945911427153

Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0193945911427153

Treatment adherence in chronic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0193945911427153

Adjusting and censoring electronic monitoring device data. Implications for study outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0193945911427153

Doctor-patient communication in glaucoma care: analysis of videotaped encounters in community-based office practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0193945911427153

Using pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the Glaucoma Adherence and Persistency Study (GAPS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0193945911427153

Effect of audible and visual reminders on adherence in glaucoma patients using a commercially available dosing aid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0193945911427153

Developments in dosing aids and adherence devices for glaucoma therapy: current and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0193945911427153

Adherence to antiretroviral medications in HIV: differences in data collected via self-report and electronic monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0193945911427153

A comparison study of multiple measures of adherence to HIV protease inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0193945911427153

A measurement model of medication adherence to highly active antiretroviral therapy and its relation to viral load in HIV-positive adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0193945911427153

Are you compliant with addressing glaucoma adherence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0193945911427153

Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0193945911427153

Assessing antiretroviral adherence via electronic drug monitoring and self-report: an examination of key methodological issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0193945911427153

Adherence in glaucoma: objective measurements of once-daily and adjunctive medication use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0193945911427153

Do adherence rates and glaucomatous visual field progression correlate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0193945911427153

What is a missed dose? Implications for construct validity and patient adherence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0193945911427153

Two-year treatment patterns and costs in glaucoma patients initiating treatment with prostaglandin analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0193945911427153

Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0193945911427153

First-year treatment patterns among new initiators of topical prostaglandin analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0193945911427153

21 January 2018

Identifiers

DOI

10.1177/0193945911427153

1 reference

6 December 2017

1 reference